WST - West Pharmaceutical Services - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

WST is currently covered by 6 analysts with an average price target of $275.64. This is a potential upside of $59 (27.23%) from yesterday's end of day stock price of $216.64.

West Pharmaceutical Services's activity chart (see below) currently has 29 price targets and 36 ratings on display. The stock rating distribution of WST is 68.42% BUY and 31.58% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.76% with an average time for these price targets to be met of 73.29 days.

Highest price target for WST is $390, Lowest price target is $325, average price target is $378.83.

Most recent stock forecast was given by PAUL KNIGHT from KEYBANK on 13-Feb-2025. First documented stock forecast 20-Feb-2017.

Best performing analysts who are covering WST - West Pharmaceutical Services:

Paul Knight Derik De Bruin Jeff Johnson Juan Avendano Gregg Orrill John Sourbeer David Windley

Currently out of the existing stock ratings of WST, 13 are a BUY (68.42%), 6 are a HOLD (31.58%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$325

$111.94 (52.54%)

$470

3 months 3 days ago
(13-Feb-2025)

6/11 (54.55%)

$110.27 (51.35%)

181

Buy

$355

$141.94 (66.62%)

$405

5 months 4 days ago
(12-Dec-2024)

2/3 (66.67%)

$25.16 (7.63%)

60

Buy

$390

$176.94 (83.05%)

$350

5 months 5 days ago
(11-Dec-2024)

5/7 (71.43%)

$58.59 (17.68%)

21

Buy

$390

$176.94 (83.05%)

$375

5 months 5 days ago
(11-Dec-2024)

2/3 (66.67%)

$58.59 (17.68%)

19

Buy

$423

$209.94 (98.54%)

$536

1 years 3 months 1 days ago
(15-Feb-2024)

4/6 (66.67%)

$61.85 (17.13%)

102

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is WST (West Pharmaceutical Services) average time for price targets to be met?

On average it took 73.29 days on average for the stock forecasts to be realized with a an average price target met ratio 72.76

Which analyst has the current highest performing score on WST (West Pharmaceutical Services) with a proven track record?

PAUL KNIGHT

Which analyst has the current lower performing score on WST (West Pharmaceutical Services) with a proven track record?

DAVID WINDLEY

Which analyst has the most public recommendations on WST (West Pharmaceutical Services)?

Paul Knight works at KEYBANK and has 4 price targets and 4 ratings on WST

Which analyst is the currently most bullish on WST (West Pharmaceutical Services)?

David Windley with highest potential upside - $209.94

Which analyst is the currently most reserved on WST (West Pharmaceutical Services)?

Jeff Johnson with lowest potential downside - $27.84

West Pharmaceutical Services in the News

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST).   Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to...

WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against West Pharmaceutical Services, Inc. and Encourages Investors to Contact the Firm

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West Pharmaceutical” or the “Company”) (NYSE:WST) in the United States District Court for the Eastern District of Pennsylvania on behalf of...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?